Clinical Trial Update: Improved Diagnosis of Congenital Heart Disease by Magnetic Resonance Imaging Using Vasovist [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining whether MRI with Vasovist (gadofosveset trisodium) improves diagnosis of congenital heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• Vasovist (gadofosveset trisodium)

Snippet

Sponsor: Guy's Hospital | Conditions: Congenital Heart Disease | Phase 4 | Status: UNKNOWN